Previous studies on invasive assessment of collateral function in patients with a chronic total occlusion (CTO) have displayed only a limited increase in collateral flow and high occurrence of coronary steal during pharmacological stress. This could question the necessity for ischaemia testing prior to revascularization of CTOs in the presence of myocardial viability. The purpose of the present study was to determine the prevalence of perfusion impairments in patients with a CTO as assessed by [
Introduction
Chronic coronary total occlusions (CTO) are encountered in up to one-third of patients with known or suspected coronary artery disease (CAD). 1 -3 A CTO is defined as a native coronary artery with complete discontinuity of contrast opacification and TIMI flow grade 0 or 1 for ≥3 months. 4 -6 Successful percutaneous coronary intervention (PCI) of a CTO is associated with symptom relief, recovery of left ventricular function, and improved survival as opposed to patients in whom the procedure was unsuccessful. 3, 5, 7, 8 Still, patients with a CTO are less likely to be treated with percutaneous revascularization. 1 The reluctance of physicians to refer patients for PCI of a CTO is based on lower procedural success, traditionally higher complication rates, contrast and radiation burden, and potentially the assumption that angiographically well-developed collateral arteries (Rentrop grade 2 -3) prevent myocardial ischaemia. 5, 9 Consequently, non-invasive evaluation of myocardial ischaemia and viability has been proposed to justify percutaneous revascularization of a documented CTO. 10, 11 An ischaemic burden of ≥10% has been considered of prognostic value and has been incorporated in those decision schemes. 12 However, these decision schemes are mainly based on the uncertainty of the hemodynamic significance of nonocclusive CAD, whereas CTOs are purely dependent on collateral flow. 13, 14 Previous invasive flow investigations have demonstrated the inability of collateral arteries to comply with the demand during exercise. 15, 16 This could question the necessity for ischaemia testing prior to revascularization of CTOs in the presence of myocardial viability. The present study was designed to evaluate the prevalence and extent of absolute myocardial perfusion impairment using cardiac positron emision tomography (PET) in patients with a documented CTO and a preserved left ventricular ejection fraction (LVEF).
Methods

Study design and participants
All CTO patients considered for percutaneous revascularization at the VU University Medical Center are analysed in a dedicated programme with two experienced CTO operators. Invasive coronary angiograms, myocardial viability, ischaemia, and cardiac symptoms of all patients were analysed to determine indication for revascularization and a prospective database of all patients is maintained. Symptomatic as well as asymptomatic patients are included in this database. Patients with a documented CTO referred for [ 15 O]H 2 O PET to assess myocardial blood flow (MBF) were included in the present study. Inclusion criteria were a documented CTO of a native coronary artery and a preserved LVEF (≥50%) on echocardiography or magnetic resonance imaging to guarantee viable myocardium of the downstream myocardial territory of the CTO. Exclusion criteria were symptomatic asthma, pregnancy, high degree AV-block, and three-vessel disease. The study was approved by the institutional ethics committee.
Angiographic CTO characteristics
Pre-interventional invasive coronary angiograms (ICA) were evaluated by two experienced CTO operators (P.K. and A.N.) during a consensus meeting to determine angiographic CTO characteristics. A CTO was defined as an occlusion on ICA with no or minimal antegrade filling of the distal vessel (TIMI 0 -I). 5 Collateral connection score was graded as no visible connection (CC0), thread-like connection (CC1), or small branch-like connection (CC2). 15 Collateral flow was scored based on contralateral filling of the occluded artery consistent with the Rentrop and Cohen classification. 17 Angiographic CTO morphology was assessed according to the Japanese CTO score. 18 
Positron emission tomography
PET studies using [
15
O]H 2 O were performed as described previously. 19 Briefly, patients were scanned on an Ingenuity TF 128 PET/CT scanner (Philips Healthcare, Best, the Netherlands). All patients were asked to refrain from any caffeine or xanthine containing products for 24 h prior to scanning. After a scout-CT for patient positioning, a dynamic emission scan was performed at rest followed by an identical scan during intravenous adenosine (140 mg kg 21 min
21
) induced hyperaemia. Parametric MBF images were generated and analysed quantitatively by an experienced analyst using Cardiac VUer. 20 
Results
Clinical characteristics
Seventy-six consecutive patients with a documented CTO and preserved LVEF who underwent [ Table 1 . Seventeen patients (22%) were asymptomatic at time of cardiac PET, whilst the majority of patients were analysed for stable angina (n ¼ 43, 57%), dyspnoea (n ¼ 13, 17%), or unstable angina (n ¼ 3, 4%). Asymptomatic patients were analysed to determine indication for PCI CTO after PCI for (non-)ST-elevated myocardial infarction (n ¼ 12), staged PCI for stable angina (n ¼ 3), cardiovascular screening (n ¼ 1), or an episode of ventricular arrhythmia (n ¼ 1). CTOs were predominantly located in the RCA (n ¼ 52, 68%) and less frequently in the LAD (n ¼ 15, 20%), or Cx (n ¼ 9, 12%). The majority of the included patients had single-vessel disease (CTO), whilst 17 patients (22%) had an additional obstructive lesion in a non-CTO vessel. Medical history exposed 34 (45%) patients with prior myocardial infarction, 53 (70%) patients with previous PCI, and in 5 (7%) patients coronary artery bypass grafting was performed previously. In six (8%) patients, with prior myocardial infarction, pathologic Q-waves of the downstream CTO territory were observed on electrocardiogram. In all these six patients myocardial viability of the CTO territory was confirmed with late gadolinium enhanced magnetic resonance imaging (,50% transmurality). CTO characteristics are listed in Table 2 .
Hemodynamic conditions during PET
The hemodynamic conditions during baseline and hyperaemia PET are summarized in Table 3 . Heart rate and rate pressure product increased from baseline to hyperaemia (both P , 0.001). Systolic blood pressure and mean arterial pressure were significantly lower during hyperaemia when compared with baseline PET (P , 0.01 and P ¼ 0.04, respectively).
Baseline MBF
Global MBF was 0.95 + 0.22 mL min 21 g 21 , whereas MBF of the target area during baseline was significantly lower when compared with the remote area (0.89 + 0.25 vs. 0.98 + 0.23 mL min 21 g 21 , P , 0.001). A high J-CTO score (≥3) resulted in a more reduced baseline perfusion (P , 0.01), whilst baseline perfusion was comparable for different CC scores and Rentrop grades ( Table 4 ). An example of severely impaired baseline perfusion in the presence of angiographically well-developed collateral arteries is illustrated in Figure 1 . patients (1.36 + 0.37 vs. 1.37 + 0.37 mL min 21 g 21 , P ¼ 0.96, respectively). Univariate analysis showed that age, J-CTO score, CTO calcification, and the presence of a microchannel had a significant impact on hyperaemic MBF of the downstream CTO territory, whilst multivariate analysis specified that only CTO calcification and the presence of a microchannel were independently related to hyperaemic MBF of the CTO territory ( Table 5) .
Hyperaemic MBF
Coronary flow reserve
Mean CFR of target area was significantly lower compared with the mean CFR of remote area (1.67 + 0.80 vs. 2.79 + 0.84, P , 0.001). Only 7 (9%) patients displayed a preserved CFR of ≥2.50 in the target area. Coronary steal (CFR ,1.0) of the target area was observed in 10 (13%) patients. Univariate analysis did not identify any predictors for differences in CFR of the CTO territory ( Table 5) .
Discussion
The present study was conducted to evaluate the extent of PET perfusion deficits in the presence of a documented CTO. Results indicate that the vast majority of patients demonstrate severe perfusion impairment on cardiac PET independent of CC score and Rentrop grade in the co-existence of viable myocardium.
CTO characteristics
Well-developed collateral arteries preserve left ventricular function in the manifestation of a coronary occlusion. 22 In the present cohort of CTO patients with a preserved LVEF, predominantly welldeveloped collateral arteries were observed. Almost all patients displayed a CC score ≥1 and Rentrop grade ≥2, which is in line with previous studies in patients without prior Q-wave myocardial infarction. 15, 16 However, intracoronary flow and pressure measurements allow for a more accurate estimation of the functional capacity of the collateral circulation than coronary angiography. 23 These invasive measurements have demonstrated the inability of the collateral arteries to comply with increased oxygen demand, which is confirmed by the present data. 16, 24 Also, van der Hoeven et al.
25
showed that when using invasive pressure measurements, the mean collateral flow index (CFI) in CTO patients is only 0.39, pointing at limited functional collateral capacity in the majority of patients, albeit with a large heterogeneity. Interestingly, baseline and hyperaemic perfusion were significantly lower in patients with unfavourable occlusion characteristics as expressed by higher J-CTO. It could be hypothesized that a high J-CTO represents more pronounced CAD, which is correlated with increased myocardial perfusion impairment. In addition, collateral supply to the CTO territory could be hampered by obstructive or diffuse disease of the donor vessels. 
CTO, chronic total occlusion; standard deviation; MBF, myocardial blood flow; CFR, coronary flow reserve; RFR, relative flow reserve; RCA, right coronary artery; LAD, left anterior descending artery; CX, circumflex artery; J-CTO, Japanese chronic total occlusion; CC, collateral connection; Intergroup significance was determined with ANOVA and a post hoc Bonferroni for localizing the source of the difference. *P , 0.01 vs. J-CTO ≥3. **P , 0.05 vs. J-CTO 2. ***P ¼ 0.02 vs. J-CTO ≥3.
study, possibly altering the hyperaemic perfusion of the downstream CTO territory. However, there was no significant difference in hyperaemic perfusion of the downstream CTO as well as remote area between patients with single-vessel CTO and two-vessel disease (data not shown, P ¼ 0.42 and 0.20, respectively).
Baseline perfusion
Baseline PET of the present study showed that myocardial perfusion was reduced in the downstream CTO area during resting conditions. This finding was not completely unexpected since multiple studies have observed, with invasive pressure interrogation, that invasive CFI was ,0.8 in the majority of CTO patients. 24, 25 Given the wide variation of perfusion demand during resting conditions, these results do not imply that those patients are in a continuous ischaemic state. However, it may emphasize the limited functional reserve of the microvasculature in collateral-depending myocardium or represent downregulation of flow as an early sign of hibernation. 26 
Hyperaemic myocardial perfusion
Multiple studies have shown that hyperaemic invasive fractional flow reserve of CTOs is severely reduced, and that hyperaemic Doppler flow distal to the CTO is impaired in a significant proportion of patients (.90%). 15, 16, 24 Also, studies using SPECT showed extensive relative stress perfusion deficits. 27, 28 However, actual quantitative myocardial flow data of CTO patients are lacking. The present study demonstrated a severely compromised hyperaemic myocardial perfusion of the downstream CTO area, and a reduction of almost 50% when compared with remote perfusion. 29, 30 Furthermore, 96% of the patients displayed a perfusion target to remote perfusion difference ≥25% (RFR ≤0.75). This would be comparable with a fractional flow reserve ≤0.75 in the co-existence of completely normal remote perfusion, 31 although, the presence of a CTO is associated with a lower FFR of the contralateral vessel due to donor collateral supply. 16, 32 This suggests that remote perfusion in CTO patients is an unsuitable reference standard for RFR calculation as it would underestimate the relative perfusion impairment. In addition to the prevalence and severity of perfusion impairment, CTO patients with large ischaemic burden have a worse cardiovascular outcome compared with those with small ischaemic burden. 33 28 identified an ischaemic extent of 12.5% at nuclear imaging as an optimal cut-off to select patients who will be likely to have significant ischaemia reduction after PCI of a CTO. According to the standardized 17-segment model of the American Heart Association, two myocardial segments equal 12% of the myocardium. 21 In the present study, 72 (95%) patients revealed ≥2 ischaemic myocardial segments and could be considered for revascularization. However, Simonsen et al. 34 showed that the benefit of revascularization is more marked in patients with a LVEF ,50%, suggesting that LVEF should also be included in the decision making process.
Coronary flow reserve
Werner et al. 16 reported coronary steal during hyperaemic Doppler flow measurements in one-third of patients with a CTO. In the present study, myocardial steal (i.e. CFR ,1.0) was only observed in a small subset (13%) of patients. 35 In case of antegrade blood flow, flow of the epicardial vessel will be distributed to the myocardium distal to the location of the Doppler flow wire. Under these circumstances, the Doppler flow wire will detect representative flow velocity to the downstream myocardial territory. However, if flow originates from the distal end of the vessel, as with collateral flow, a significant proportion of the blood flow could be disseminated to the myocardium before arriving at the Doppler flow wire. This phenomenon could hamper the accuracy of Doppler flow measurements distal of a CTO, especially during hyperaemia as microvascular resistance is minimized.
Limitations
Results should not be generalized to completely different patients groups (i.e. heart failure), particularly since some degree of patient selection bias is present when using clinical populations. Furthermore, patients with small vessel CTOs may not even be considered for PCI CTO and are missing from this analysis. Also, capacity of the collateral circulation was only graded by angiographic scoring rather than using invasively measured CFI. Last, the present study did not analyse response to revascularization, therefore, it remains 
Conclusions
The vast majority of CTO patients with a preserved LVEF showed significant perfusion impairment, even in the presence of angiographically well-developed collateral arteries. These results suggest that collateral function during increased blood flow demand in viable myocardium is predominantly insufficient and that revascularization should be considered. Given the large perfusion deficits in this patient population, PET might prove as valuable surrogate end point in future clinical trials to determine the effects of mechanical or pharmacological (re)vascularization.
Impact on daily practice
These results suggest that additional ischaemia testing prior to revascularization of a CTO should be questioned, since the proportion of patients with PET-defined stress perfusion deficits is exceptionally high in CTO patients with a preserved left ventricular ejection fraction. 
